(Date:12/2/2009)...LLE, Gabon, December 2 , ...roblem and Heritage" , Coinciding with th...0 the,Gabonese Republic is hosting an internationa... safeguarding biological resources in Africa. The,...e leaders, ministers,scientific experts, private ...
(Date:12/2/2009)...DGE, Mass., Dec. 2 TechConnect Wor...nology development and product integration in clea...ecember 11th deadline for technology abstracts and...r, TechConnect World, in association with the Nano...Clean Technology and Sustainable Industries Organi...
(Date:12/2/2009)...ORE, Dec. 2 S*BIO Pte Ltd today an...inhibitor, SB1518, at The American Society of Hema...rleans. ,, Data will be presented on the clinic...of SB1518 detailing its safety, tolerability and p...dose levels ranging from 100 to 600 mg. These dose...
(Date:12/2/2009)...NG, China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pha...SE: SCR ), a leading pharmaceutical company,spec...rketing of branded,generic and proprietary pharmac... drugs have been included in China,s National Drug...China,s Ministry of Human Resources and Social,Sec...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3(Date:12/2/2009)... , NEW YORK, Dec. 2 Report...port is available in its catalogue: ,, Chiral ... Trends ,, http://www.reportlinker.com/p01642...arket-Trends.html ,, The fast developing smal...a flurry of activity with pharmaceutical companies...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportl...ort is available in its catalogue: ,, Hepatiti...rket Trends & Opportunities ,, http://www...herapeutics---A-Global-Update-of-Market-Trends--Op...d for all these years of meager clinical outcomes ...
(Date:12/2/2009)... , LAS ANGELES, December 2 /PRNewswire-Fir...I) announced today that it would initiate a progra...em informed of the significant,progress which Foun...lan, as,well as to provide shareholders with regul...Dunn Capital Partners and others. , Fount...
Breaking Medicine Technology:Reportlinker Adds Chiral Technology - International Technology & Market Trends 2Reportlinker Adds Chiral Technology - International Technology & Market Trends 3Reportlinker Adds Chiral Technology - International Technology & Market Trends 4Reportlinker Adds Chiral Technology - International Technology & Market Trends 5Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 8Fountain Healthy Aging Inc Business Update For Shareholders 2Fountain Healthy Aging Inc Business Update For Shareholders 3Pharmacyclics Inc Rights Offering Oversubscribed 13381 1Pharmacyclics Inc Rights Offering Oversubscribed 13381 2Pharmacyclics Inc Rights Offering Oversubscribed 13381 3Winter Park Home to World 26apos 3Bs Foremost Producers of Large Scale Decontamination Equipment 13379 1Winter Park Home to World 26apos 3Bs Foremost Producers of Large Scale Decontamination Equipment 13379 2Germgards New Room Temperature Surgical Instrument Sterilizer Achieves Total Cycle Time of Three Minutes 53704 1Germgards New Room Temperature Surgical Instrument Sterilizer Achieves Total Cycle Time of Three Minutes 53704 2Germgards New Room Temperature Surgical Instrument Sterilizer Achieves Total Cycle Time of Three Minutes 53704 3